Cathie Wood’s CollPlant Biotechnologies CLGN Stock Holding History

Cathie Wood’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-235,660	Closed	-$2.19M	–	272
2022 Q2	$2.19M	Buy	235,660 +7,003	+3%	+$64.3K	0.01%	180
2022 Q1	$2.57M	Buy	228,657 +63,203	+38%	+$695K	0.01%	192
2021 Q4	$2.71M	Sell	165,454 -25,836	-14%	-$461K	0.01%	221
2021 Q3	$3.23M	Buy	+191,290	New	+$3.44M	0.01%	229

Other funds holding CLGN

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

IMOV

Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BFEC

Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

SQA

Simon Quick Advisors Morristown, New Jersey $2.48B AUM 21.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Cathie Wood's CLGN Position: Q3 2022 in Review

Cathie Wood sold out of CollPlant Biotechnologies (CLGN) in Q3 2022, closing a stake of 235,660 shares — an estimated $2.19M sold.

Cathie Wood first reported a position in CLGN in Q3 2021 and held it in 4 quarters. The position peaked at $3.23M in Q3 2021. 21 funds tracked by Wall St. Rank hold CLGN as of Q3 2022.

Cathie Wood reported no remaining CollPlant Biotechnologies position as of Q3 2022 after selling out during the quarter.
Cathie Wood sold 235,660 CollPlant Biotechnologies shares in Q3 2022, an estimated $2.19M.
Cathie Wood first reported a position in CollPlant Biotechnologies in Q3 2021 and held it in 4 quarters.
Cathie Wood's CollPlant Biotechnologies position peaked at $3.23M in Q3 2021.
21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2022.

Based on ARK Investment Management's 13F filing for Q3 2022, filed 17 Oct 2022.